mRNA Innovation – Going Beyond Human Therapeutics
11 August 2025 NSW Develops World-First Foot and Mouth Disease Vaccine, with Support from TIA’s RNA Products capability Australia is now among a handful of countries with the capability to produce a vaccine to protect livestock against foot and mouth disease (FMD), following the announcement of a world-first mRNA vaccine developed through a $20 million […]